In July 2013 the Jamaica Anti-Doping Commission (JADCO) has reported an anti-doping rule violation against the Athlete Asafa Powell after his A and B samples tested positive for the prohibited substance oxilofrine (methylsynephrine).
After notification the Athlete admitted the violation and accepted a provisional suspension. The Athlete filed a statement in his defence and was heard for the Jamaica Anti-Doping (JAD) Disciplinary Panel.
The Athlete stated that he used the supplement Epiphany D1, which contained the prohibited substance and provided by his physical therapist, and asserted that he checked the ingredients of his supplements before using.
The Panel considers that the Athlete had no intention to enhance his sport performance but he also acted with fault and negligence. Therefore the JAD Disciplinary Panel decides on 1 May 2014 to impose a 18 month period of ineligibility on the Athlete, starting on the date of the sample collection, i.e. on 21 June 2013 until 20 December 2014.
